Edward Damiano
Fortuna: 31 M $ al 31/05/2026
Fortuna: 31 M $ al 31/05/2026
Edward R.
Damiano was the founder of Beta Bionics, Inc., where the founding year was 2015 and the title held was Executive Chairman from 2022 to 2025.
Dr. Damiano's current job is at Boston University, starting in 2023 with the title of Professor.
Education history includes a graduate degree from Washington University in St. Louis and both an undergraduate and a doctorate degree from Rensselaer Polytechnic Institute.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
BETA BIONICS, INC. 5,68 % | 30/01/2025 | 2.533.000 ( 5,68 % ) | 31 M $ | 31/05/2026 |
BETA BIONICS, INC. 0,13 % | 01/12/2024 | 7.164 ( 0,13 % ) | 86 828 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
Boston University
Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/07/2023 |
| Empresas | Cargo | Fin |
|---|---|---|
| BETA BIONICS, INC. | Director Ejecutivo | 02/03/2022 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Washington University in St. Louis
Washington University in St. Louis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boston University
Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rensselaer Polytechnic Institute
Rensselaer Polytechnic Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Beta Bionics, Inc.
Beta Bionics, Inc. Medical SpecialtiesHealth Technology Designs, develops, manufactures and markets medical devices for diabetes disease | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.